These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 33144028)
1. Relative incidence and predictors of pulmonary arterial hypertension complicating type 2 diabetes: The Fremantle Diabetes Study Phase I. Nundlall N; Playford D; Davis TME; Davis WA J Diabetes Complications; 2021 Feb; 35(2):107773. PubMed ID: 33144028 [TBL] [Abstract][Full Text] [Related]
2. Temporal Trends in Incident Hospitalization for Diabetes-Related Foot Ulcer in Type 2 Diabetes: The Fremantle Diabetes Study. Hamilton EJ; Davis WA; Siru R; Baba M; Norman PE; Davis TME Diabetes Care; 2021 Mar; 44(3):722-730. PubMed ID: 33441420 [TBL] [Abstract][Full Text] [Related]
3. Temporal Trends in Cardiovascular Complications in People With or Without Type 2 Diabetes: The Fremantle Diabetes Study. Davis WA; Gregg EW; Davis TME J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32352534 [TBL] [Abstract][Full Text] [Related]
4. Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I. Rajapaksa R; Davis WA; Davis TME BMJ Open Diabetes Res Care; 2023 Jul; 11(4):. PubMed ID: 37487648 [TBL] [Abstract][Full Text] [Related]
5. Incidence and Determinants of Intraocular Lens Implantation in Type 2 Diabetes: The Fremantle Diabetes Study Phase II. Drinkwater JJ; Davis TME; Turner AW; Bruce DG; Davis WA Diabetes Care; 2019 Feb; 42(2):288-296. PubMed ID: 30523034 [TBL] [Abstract][Full Text] [Related]
6. Dementia onset, incidence and risk in type 2 diabetes: a matched cohort study with the Fremantle Diabetes Study Phase I. Davis WA; Zilkens RR; Starkstein SE; Davis TM; Bruce DG Diabetologia; 2017 Jan; 60(1):89-97. PubMed ID: 27717960 [TBL] [Abstract][Full Text] [Related]
7. Influence of Renin-Angiotensin System Inhibitors on Lower-Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II. Davis TME; Davis WA Diabetes Care; 2020 Sep; 43(9):2113-2120. PubMed ID: 32616610 [TBL] [Abstract][Full Text] [Related]
8. Influence of Premature Mortality on the Link Between Type 2 Diabetes and Hip Fracture: The Fremantle Diabetes Study. Hamilton E; Davis WA; Bruce DG; Davis TM J Clin Endocrinol Metab; 2017 Feb; 102(2):551-559. PubMed ID: 27880070 [TBL] [Abstract][Full Text] [Related]
9. Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes Study. Davis TME; Peters KE; Chubb SAP; Adams LA; Jeffrey GP; Davis WA J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33114323 [TBL] [Abstract][Full Text] [Related]
10. Incidence and precipitants of hospitalization for pancreatitis in people with diabetes: the Fremantle Diabetes Study. Davis TM; Drinkwater J; Davis WA Diabet Med; 2014 Aug; 31(8):913-9. PubMed ID: 24661305 [TBL] [Abstract][Full Text] [Related]
11. Temporal trends in chronic complications of diabetes by sex in community-based people with type 2 diabetes: the Fremantle Diabetes Study. Davis WA; Davis TME Cardiovasc Diabetol; 2023 Sep; 22(1):253. PubMed ID: 37716976 [TBL] [Abstract][Full Text] [Related]
12. Incidence and predictors of hospitalization for bacterial infection in community-based patients with type 2 diabetes: the fremantle diabetes study. Hamilton EJ; Martin N; Makepeace A; Sillars BA; Davis WA; Davis TM PLoS One; 2013; 8(3):e60502. PubMed ID: 23536910 [TBL] [Abstract][Full Text] [Related]
13. Temporal changes in the incidence and predictors of severe hypoglycaemia in type 2 diabetes: The Fremantle Diabetes Study. Davis TME; Bruce DG; Finn J; Curtis BH; Barraclough H; Davis WA Diabetes Obes Metab; 2019 Mar; 21(3):648-657. PubMed ID: 30370611 [TBL] [Abstract][Full Text] [Related]
14. Dementia complicating type 2 diabetes and the influence of premature mortality: the Fremantle Diabetes Study. Bruce DG; Davis TME; Davis WA Acta Diabetol; 2019 Jul; 56(7):767-776. PubMed ID: 30945048 [TBL] [Abstract][Full Text] [Related]
15. Incidence and predictors of idiopathic pulmonary fibrosis complicating Type 2 diabetes: the Fremantle Diabetes Study Phase I. Navaratnam V; Davis TME; Hubbard R; Davis WA Intern Med J; 2021 Feb; 51(2):276-279. PubMed ID: 33631852 [TBL] [Abstract][Full Text] [Related]
16. Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle Diabetes Study. Magliano DJ; Davis WA; Shaw JE; Bruce DG; Davis TM Eur J Endocrinol; 2012 Oct; 167(4):589-99. PubMed ID: 22893694 [TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Davis WA; Hamilton EJ; Bruce DG; Davis TME Diabetes Care; 2019 Jan; 42(1):102-109. PubMed ID: 30455327 [TBL] [Abstract][Full Text] [Related]
18. Temporal Trends in Renal Replacement Therapy in Community-Based People with or without Type 2 Diabetes: The Fremantle Diabetes Study. Davis WA; Chakera A; Gregg E; McAullay D; Davis TME J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160152 [TBL] [Abstract][Full Text] [Related]
19. Incidence and predictors of hospitalization for tendon rupture in type 2 diabetes: the Fremantle diabetes study. Zakaria MH; Davis WA; Davis TM Diabet Med; 2014 Apr; 31(4):425-30. PubMed ID: 24151882 [TBL] [Abstract][Full Text] [Related]
20. Incidence and associates of diabetic ketoacidosis in a community-based cohort: the Fremantle Diabetes Study Phase II. Davis TME; Davis W BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32139599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]